The communications technology firm has completed its merger with Core Gaming and will relaunch on October 7th as an artificial intelligence holding company.
Regulators expedite review for ALTO-101, targeting a key aspect of schizophrenia with no currently approved treatments.
Internal U.S. Army memo flags 'fundamental security' vulnerabilities in a key battlefield communications network, raising contract concerns.
Blaze at the massive El Segundo facility, a key fuel supplier for Southern California, raises concerns over potential price impacts.
Shares of the recently-listed marine fuel provider hit all-time lows on massive volume as the market reacts to unspecified executive shifts.
The sale of the controlling interest in the insurance platform represents a significant and rapid return on investment for White Mountains.
Settlement with Dr. Reddy's Laboratories shields key drugs NEXLETOL and NEXLIZET from generic competition until 2040, boosting investor confidence.
With a potential market of 128 million in the U.S., analysts see blockbuster potential for the new presbyopia treatment.